1. P-284Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): "first-in-cancer" phase Ib study. (2nd July 2019) Authors: Van Cutsem, E; Shitara, K; Deng, W; Vaury, A; Tseng, L; Wang, X; Millholland, J; Shilkrut, M; Mookerjee, B; Jonasch, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗